Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171440 · ClinicalTrials.gov registry record · NA
Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy
A NA study of Pancreaticoduodenectomy, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 2
- Study locations
NCT04171440: Completed NA study of Pancreaticoduodenectomy, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT04171440 is a NA study of Pancreaticoduodenectomy that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04171440, a NA study of Pancreaticoduodenectomy, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a multi-site prospective, single arm, observational study examining the outcomes of robotic pancreaticoduodenectomy.
Primary Outcome
Days from date of intervention to discharge
Conditions Studied
Interventions
- PROCEDURE robotic pancreaticoduodenectomy
Study Locations (2)
Maryland
- Johns Hopkins Hospital - Baltimore
North Carolina
- Atrium Health - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
What the finished NCT04171440 record still lists
NCT04171440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Pancreaticoduodenectomy appearing as the primary indexed condition, and to 1 intervention - of which robotic pancreaticoduodenectomy is the first listed.
NCT04171440 reports a single indexed study location in Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04171440 about?
NCT04171440 is a clinical study titled "Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy". This is a multi-site prospective, single arm, observational study examining the outcomes of robotic pancreaticoduodenectomy.
What is the current status of trial NCT04171440?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2020-02-18. Estimated completion is 2025-10-01.
What conditions does trial NCT04171440 study?
This clinical trial studies the following conditions: Pancreaticoduodenectomy.
What interventions are being tested in trial NCT04171440?
The interventions under investigation include: robotic pancreaticoduodenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT04171440?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04171440 being conducted?
This trial has 2 study locations across Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreaticoduodenectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04171440's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI